
Opinion|Videos|June 5, 2024
An Overview of Potential Treatment Adverse Effects
An expert on chronic lymphocytic leukemia discusses adverse effects encountered by patients who are receiving BTK inhibitors or venetoclax-based regimens.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- What types of adverse effects may patients encounter with BTK inhibitor therapy? Venetoclax?
- How are these adverse effects typically managed and how does a multidisciplinary team contribute to this process?
- What guidance do you offer to patients to assist them in effective management of potential adverse events?
Advertisement
Advertisement
Advertisement
Trending on CURE
1
New Myelofibrosis Guidelines Back Wider Gene Testing at Diagnosis
2
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
3
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
4
Allowing Myself to Lean into a False Reality: The Comfort of Hope
5



